Traferox Technologies Receives FDA Premarket Approval for the TorEx Lung Perfusion System

MISSISSAUGA, Ontario, July 22, 2026 (GLOBE NEWSWIRE) — Traferox Technologies, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for the TorEx® Lung Perfusion System with TorEx Lung Perfusate (TLP), an ex vivo lung perfusion (EVLP) platform designed to enable functional assessment of donor lungs outside the body […]